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Correlation of Population Specific Risk Factors and
Prevalence of Developing Severe Hypoglycemia
Whitney Dovel, PharmD, Shalyn Cox, PharmD, BCPS
Background

Methods

Results

Limitations

Tendency for tighter glycemic control using
sliding-scale and long-acting (LA) insulin in
hospitalized patients leads to higher risk of
severe hypoglycemia. Commonly, we don’t use
validated strategies for calculating insulin
requirements in admitted patients and
infrequently complete the recommended
follow-up after insulin initiation or
adjustments. Centers for Medicare and
Medicaid Services (CMS) defines blood
glucose of <40 mg/dL within 24-hours of
administration of anti-diabetic medication as
preventable harm.1 The FADOI-DIAMOND
study in 2016 showed mortality increased by
2-3 times after an inpatient hypoglycemic
2
event. Covenant Medical Center (CMC) had
a severe hypoglycemia rate of 8.97% in 2021,
almost double the Providence ministry goal
of 4.5% based on a threshold of blood
glucose <50 mg/dL with at-risk patients
being all with anti-diabetic medication orders.
Elliott, et al, validated a weighted risk score
calculator to identify patients for intervention
using age, renal function (CrCl), weight, and
insulin dose in units/kg/day.3 When applied
to our population, it did not show association
of risk in known hypoglycemic patients from
a previous MUE. That MUE also showed that
patients have decreasing blood glucose trends
before severe hypoglycemic event.

• Primary outcome - Measure association of
patients experiencing severe hypoglycemia
while admitted to CMC with various
independent variables

• Statistically significant associations were
found with developing severe hypoglycemia
and use of LA insulin, BMI categories
<18.5, 18.5 to 24.99, and 30 to 34.99, and
CrCl <60 ml/min. [Figure 3]
• No difference was found in BID use of LA
insulin, SU use, steroid use or tapering, or
diet.
• 33.95% with CKD diagnosis compared to
52% of patients with CrCl <60 mL/min.
• 14 (39.5%) patients had a blood glucose of
<90 within the previous 24 hours.
• Only 14 of 43 (32.6%) patients who
experienced a severe hypoglycemic event
were on floors with a pharmacist rounding
daily. [Figure 2]

• Dataset not fully representative of
population with severe hypoglycemia
incidence of 6.63% compared to reported
rate of 8.67% for quarter 1.
• Data collection cut short due to transitions
in EHR leading to 70 severe hypoglycemic
events not included.
• Large COVID population affects average
age, steroid use, insulin use, and comorbidities, as well as large change in
workload on staff.
• ICD-10 coding unreliable or AKI on date
of patient admission analyzed causing
inconsistencies.

•
•
•
•
•

Increased age
• Low body weight
ESRD/CKD
• SU use
Steroid use/taper
• NPO/decreased intake
LA insulin dosed BID
>0.5 units/kg/day of LA insulin

• Design - Retrospective chart review,
multiple linear regression
• Population - 1304 at risk patients, 736
patients reviewed, 88 excluded [Figure 1]
• Period - Quarter 1 of 2021
• Post-hoc analysis done to compare incidence
based on pharmacist rounding versus
surveillance floor.

• 7 of those 14 were on the nephrology unit

Figure 1: Patient selection.

Table 2: Statistically significant results.

Table 1: Patient demographics.

Figure 2: Breakdown of hypoglycemic events based
on floor and pharmacist coverage.

Discussion
The cause of inpatient severe hypoglycemia is
complex and requires clinical judgement to
determine patients requiring intervention.
Patients admitted to CMC with BMI <18 to
24.9 kg/m2 with renal dysfunction on LA
insulin are at highest risk of severe
hypoglycemia. More timely review of patients
with down-trending blood glucose, especially
after starting or adjusting LA insulin, can
greatly improve the incidence of severe
hypoglycemia. Pharmacists can be more
utilized to address these events and improve
management of inpatient insulin dosing.

Future Implications

Purpose
• Identify population specific risk factors for
experiencing severe hypoglycemia in
patients admitted to CMC
• Utilize the data to develop clinical
surveillance tools for more accurate
recognition of patients for intervention
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• Surveillance tools that flag patients for
review when blood glucose is <90 mg/dL
with high-risk characteristics can guide
preventative interventions.
• Development and implementation of a
pharmacist-led
insulin
management
protocol.

